Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steffen Bauer

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
European Journal of Clinical Pharmacology|December 13, 2005
The extent of induction of CYP3A by St. John's wort varies among products and is linked to hyperforin doseSilke C Mueller, Jolanta Majcher-Peszynska, Bernhard Uehleke, et al.
Clinical Pharmacology and Therapeutics|December 21, 2006
Pharmacokinetics and pharmacodynamics of rosiglitazone in relation to CYP2C8 genotypeJulia Kirchheiner, Soju Thomas, Steffen Bauer, et al.
Mabs|August 9, 2013
Ch14.18 antibody produced in CHO cells in relapsed or refractory Stage 4 neuroblastoma patients: a SIOPEN Phase 1 studyRuth Ladenstein, Silke Weixler, Bianca Baykan, et al.
Nature Ecology & Evolution|November 28, 2022
The global biodiversity framework needs a robust action agendaSander Chan, Steffen Bauer, Michele M Betsill, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
European Journal of Clinical Pharmacology|December 13, 2005
The extent of induction of CYP3A by St. John's wort varies among products and is linked to hyperforin doseSilke C Mueller, Jolanta Majcher-Peszynska, Bernhard Uehleke, et al.
Clinical Pharmacology and Therapeutics|December 21, 2006
Pharmacokinetics and pharmacodynamics of rosiglitazone in relation to CYP2C8 genotypeJulia Kirchheiner, Soju Thomas, Steffen Bauer, et al.
Mabs|August 9, 2013
Ch14.18 antibody produced in CHO cells in relapsed or refractory Stage 4 neuroblastoma patients: a SIOPEN Phase 1 studyRuth Ladenstein, Silke Weixler, Bianca Baykan, et al.
Nature Ecology & Evolution|November 28, 2022
The global biodiversity framework needs a robust action agendaSander Chan, Steffen Bauer, Michele M Betsill, et al.
Pageof 5